Highbridge Capital Management’s Medifast MED Stock Holding History

Highbridge Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,991	Closed	-$209K	–	1501
2017 Q4	$209K	Buy	+2,991	New	+$198K	﹤0.01%	1479
2017 Q2	–	Sell	-20,225	Closed	-$897K	–	1456
2017 Q1	$897K	Buy	+20,225	New	+$871K	0.01%	658
2016 Q3	–	Sell	-8,764	Closed	-$292K	–	1533
2016 Q2	$292K	Buy	+8,764	New	+$283K	﹤0.01%	1075
2015 Q1	–	Sell	-6,256	Closed	-$210K	–	1512
2014 Q4	$210K	Buy	+6,256	New	+$195K	﹤0.01%	1053
2013 Q3	–	Sell	-19,821	Closed	-$511K	–	1421
2013 Q2	$511K	Buy	+19,821	New	+$521K	0.01%	881

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Highbridge Capital Management's MED Position: Q1 2018 in Review

Highbridge Capital Management sold out of Medifast (MED) in Q1 2018, closing a stake of 2,991 shares — an estimated $209K sold.

Highbridge Capital Management first reported a position in MED in Q2 2013 and held it in 5 quarters. The position peaked at $897K in Q1 2017. 225 funds tracked by Wall St. Rank hold MED as of Q1 2018.

Highbridge Capital Management reported no remaining Medifast position as of Q1 2018 after selling out during the quarter.
Highbridge Capital Management sold 2,991 Medifast shares in Q1 2018, an estimated $209K.
Highbridge Capital Management first reported a position in Medifast in Q2 2013 and held it in 5 quarters.
Highbridge Capital Management's Medifast position peaked at $897K in Q1 2017.
225 funds tracked by Wall St. Rank held Medifast as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.